
AbbVie Inc.: shareholders and insiders
Price
$290.08
November 18, 2026Market cap $513B
What Ploutos Investor adds for AbbVie
Part of Ploutos Investor, €9.99 a month
- The full history: 15 fiscal years, from 2011
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Nov 12, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$31M
4 people
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan31%
- The rest69%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $31M by 4 people
- 2025: no buys, no sales
- 2026: no buys, sold $31M by 4 people
- Nov 12, 2026Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICERKind
- Nov 9, 2026Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICERKind
- Nov 9, 2026Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICERKind
- Nov 9, 2026Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICERKind
- Aug 14, 2026Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICERKind
- Aug 14, 2026Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICERKind
- Mar 4, 2026David Ryan PurdueSVP, ControllerKind
- Mar 2, 2026Perry C SiatisEVP, GC AND SECRETARYKind10b5-1
- Mar 2, 2026Perry C SiatisEVP, GC AND SECRETARYKind10b5-1
- Mar 2, 2026Perry C SiatisEVP, GC AND SECRETARYKind10b5-1
- Feb 25, 2026Perry C SiatisEVP, GC AND SECRETARYKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICER | 3,450 | – | – | Form 4 | |
| Nov 9, 2026 | Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICER | 16.1K | $114.36 | $1.8M | Form 4 | |
| Nov 9, 2026 | Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICER | 24.5K | $93.50 | $2.3M | Form 4 | |
| Nov 9, 2026 | Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICER | 40.6K | $293.60 | $12M | Form 4 | |
| Aug 14, 2026 | Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | 32.7K | $79.02 | $2.6M | Form 4 | |
| Aug 14, 2026 | Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | 32.7K | $250.00 | $8.2M | Form 4 | |
| Mar 4, 2026 | David Ryan PurdueSVP, Controller | 5,230 | $233.56 | $1.2M | Form 4 | |
| Mar 2, 2026 | Perry C SiatisEVP, GC AND SECRETARY | 10b5-1 | 5,777 | $233.51 | $1.3M | Form 4 |
| Mar 2, 2026 | Perry C SiatisEVP, GC AND SECRETARY | 10b5-1 | 2,600 | $235.26 | $611.7K | Form 4 |
| Mar 2, 2026 | Perry C SiatisEVP, GC AND SECRETARY | 10b5-1 | 10.3K | $234.66 | $2.4M | Form 4 |
| Feb 25, 2026 | Perry C SiatisEVP, GC AND SECRETARY | 10b5-1 | 22.4K | $230.00 | $5.1M | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jul 2, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by ABBV's officers and directors from 2013 up to November 17, 2025, 13 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 8 more, back to 2013
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Vanguard Capital ManagementShare of class7.51%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 7.51% | 133M | Apr 29, 2026 | 13G |
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- The Vanguard Group0.00%Mar 26, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Glenview CapitalIn the quarter
- Citadel Advisors (Griffin)In the quarter+547%
- D.E. ShawIn the quarter+212%
- Millennium Mgmt (Englander)In the quarter+124%
- AQR CapitalIn the quarter+127%
- Point72 (Cohen)In the quarter
- Bridgewater (Dalio)In the quarter-61%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Glenview Capital | 148.9K | $38M | 0.75% | |
| Citadel Advisors (Griffin) | 3.17M | +547% | $798M | 0.46% |
| D.E. Shaw | 2.10M | +212% | $529M | 0.33% |
| Millennium Mgmt (Englander) | 1.52M | +124% | $382M | 0.26% |
| AQR Capital | 2.02M | +127% | $507M | 0.18% |
| Point72 (Cohen) | 366.8K | $92M | 0.14% | |
| Bridgewater (Dalio) | 11.8K | -61% | $3.0M | 0.01% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 0.88% of its shares outstanding were held short, -4.3% since the report before.
- Shares held short
- 15.58M
- 0.88%
- Since the report before16.28M on Sep 30, 2026
- -4.3%
- 2.7
- 5.72M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 32%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 13.23M
- Nov 15, 2023: Shares held short 11.15M
- Nov 30, 2023: Shares held short 11.13M
- Dec 15, 2023: Shares held short 13.69M
- Dec 29, 2023: Shares held short 12.08M
- Jan 12, 2024: Shares held short 13.56M
- Jan 31, 2024: Shares held short 13.72M
- Feb 15, 2024: Shares held short 14.75M
- Feb 29, 2024: Shares held short 14.27M
- Mar 15, 2024: Shares held short 14.69M
- Mar 28, 2024: Shares held short 13.12M
- Apr 15, 2024: Shares held short 13.54M
- Apr 30, 2024: Shares held short 14.48M
- May 15, 2024: Shares held short 15.93M
- May 31, 2024: Shares held short 16.49M
- Jun 14, 2024: Shares held short 15.25M
- Jun 28, 2024: Shares held short 16.22M
- Jul 15, 2024: Shares held short 16.38M
- Jul 31, 2024: Shares held short 17.53M
- Aug 15, 2024: Shares held short 20.19M
- Aug 30, 2024: Shares held short 19.49M
- Sep 13, 2024: Shares held short 17.79M
- Sep 30, 2024: Shares held short 14.86M
- Oct 15, 2024: Shares held short 16.18M
- Oct 31, 2024: Shares held short 18.13M
- Nov 15, 2024: Shares held short 20.17M
- Nov 29, 2024: Shares held short 19.32M
- Dec 13, 2024: Shares held short 18.53M
- Dec 31, 2024: Shares held short 17.00M
- Jan 15, 2025: Shares held short 18.16M
- Jan 31, 2025: Shares held short 18.93M
- Feb 14, 2025: Shares held short 19.62M
- Feb 28, 2025: Shares held short 18.51M
- Mar 14, 2025: Shares held short 19.70M
- Mar 31, 2025: Shares held short 17.14M
- Apr 15, 2025: Shares held short 16.84M
- Apr 30, 2025: Shares held short 19.80M
- May 15, 2025: Shares held short 19.93M
- May 30, 2025: Shares held short 15.89M
- Jun 13, 2025: Shares held short 14.70M
- Jun 30, 2025: Shares held short 15.95M
- Jul 15, 2025: Shares held short 15.61M
- Jul 31, 2025: Shares held short 15.13M
- Aug 15, 2025: Shares held short 17.00M
- Aug 29, 2025: Shares held short 15.40M
- Sep 15, 2025: Shares held short 16.56M
- Sep 30, 2025: Shares held short 16.29M
- Oct 15, 2025: Shares held short 18.08M
- Oct 31, 2025: Shares held short 18.89M
- Nov 14, 2025: Shares held short 18.72M
- Nov 28, 2025: Shares held short 18.21M
- Dec 15, 2025: Shares held short 18.08M
- Dec 31, 2025: Shares held short 19.71M
- Jan 15, 2026: Shares held short 22.04M
- Jan 30, 2026: Shares held short 19.68M
- Feb 13, 2026: Shares held short 22.88M
- Feb 27, 2026: Shares held short 21.75M
- Mar 13, 2026: Shares held short 25.11M
- Mar 31, 2026: Shares held short 20.13M
- Apr 15, 2026: Shares held short 21.85M
- Apr 30, 2026: Shares held short 20.91M
- May 15, 2026: Shares held short 22.59M
- May 29, 2026: Shares held short 23.16M
- Jun 15, 2026: Shares held short 23.45M
- Jun 30, 2026: Shares held short 21.90M
- Jul 15, 2026: Shares held short 22.63M
- Jul 31, 2026: Shares held short 22.55M
- Aug 14, 2026: Shares held short 18.30M
- Aug 31, 2026: Shares held short 19.51M
- Sep 15, 2026: Shares held short 19.49M
- Sep 30, 2026: Shares held short 16.28M
- Oct 15, 2026: Shares held short 15.58M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading29.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 29.5% of the shares in the reported trades were short sales, against 35.1% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 29.5%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 35.1%
- Change
- -5.6 pts
- Short sales a dayon average, of 1.81M shares
- 534.8K
- More than atof 3,666 US-listed companies, same days
- 4%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 46.9%
- Oct 12, 2026: Short sales 52.4%
- Oct 13, 2026: Short sales 41.4%
- Oct 14, 2026: Short sales 58.1%
- Oct 15, 2026: Short sales 39.5%
- Oct 16, 2026: Short sales 17.8%
- Oct 19, 2026: Short sales 40.8%
- Oct 20, 2026: Short sales 27.5%
- Oct 21, 2026: Short sales 26.8%
- Oct 22, 2026: Short sales 23%
- Oct 23, 2026: Short sales 22.6%
- Oct 26, 2026: Short sales 29.6%
- Oct 27, 2026: Short sales 34.2%
- Oct 28, 2026: Short sales 35.6%
- Oct 29, 2026: Short sales 31.6%
- Oct 30, 2026: Short sales 38.4%
- Nov 2, 2026: Short sales 14.2%
- Nov 3, 2026: Short sales 17.3%
- Nov 4, 2026: Short sales 19.7%
- Nov 5, 2026: Short sales 35.6%
- Nov 6, 2026: Short sales 47.4%
- Nov 9, 2026: Short sales 41.4%
- Nov 10, 2026: Short sales 29.1%
- Nov 11, 2026: Short sales 27.2%
- Nov 12, 2026: Short sales 37.3%
- Nov 13, 2026: Short sales 24.1%
- Nov 16, 2026: Short sales 34.9%
- Nov 17, 2026: Short sales 32.4%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Richard A GonzalezDirectorDirectly388.9K
- Azita Saleki-gerhardtEVP, CHIEF OPERATIONS OFFICERDirectly177.3K
- Robert A. MichaelPRES & CHIEF OPERATING OFFICERDirectly98.6K
- Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICERDirectly81.1K
- Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICERDirectly74.4K
- Perry C SiatisEVP, GC AND SECRETARYDirectly17.5K
- Kevin K BuckbeeSVP, CONTROLLERDirectly12.6K
- Scott T ReentsEVP, CHIEF FINANCIAL OFFICERDirectly11.6K
- Timothy J. RichmondEVP, CHIEF HR OFFICERDirectly6,130
- David Ryan PurdueSVP, ControllerDirectly2,654
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Richard A GonzalezDirector | 388.9K | – | Mar 3, 2025 | Form 4 |
| Azita Saleki-gerhardtEVP, CHIEF OPERATIONS OFFICER | 177.3K | – | Aug 12, 2025 | Form 4 |
| Robert A. MichaelPRES & CHIEF OPERATING OFFICER | 98.6K | – | Feb 29, 2024 | Form 4 |
| Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICER | 81.1K | – | Nov 12, 2026 | Form 4 |
| Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | 74.4K | – | Aug 14, 2026 | Form 4 |
| Perry C SiatisEVP, GC AND SECRETARY | 17.5K | – | Mar 2, 2026 | Form 4 |
| Kevin K BuckbeeSVP, CONTROLLER | 12.6K | – | Feb 26, 2025 | Form 4 |
| Scott T ReentsEVP, CHIEF FINANCIAL OFFICER | 11.6K | – | Mar 14, 2025 | Form 4 |
| Timothy J. RichmondEVP, CHIEF HR OFFICER | 6,130 | – | Mar 3, 2025 | Form 4 |
| David Ryan PurdueSVP, Controller | 2,654 | – | Mar 4, 2026 | Form 4 |
A lower bound: it counts only the 10 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
10b5-1 trading plans
Since 2023 every 10-Q and 10-K says which insiders adopted or ended a trading plan (Rule 10b5-1) in the quarter: when, for how many shares, until when. A plan explains the sales that follow months before they show up on Form 4.
- Perry C. SiatisExecutive Vice President,General Counsel and SecretaryWhat happenedAdoptedNov 18, 2025Shares41.0K
- Timothy J. RichmondExecutive Vice President,Chief Human ResourcesOfficerWhat happenedAdoptedNov 27, 2024Shares83.9K
- Perry C. SiatisExecutive Vice President,General Counsel and SecretaryWhat happenedAdoptedNov 19, 2024Shares48.6K
| Person | What happened | Until | Shares | Filing |
|---|---|---|---|---|
| Perry C. SiatisExecutive Vice President,General Counsel and Secretary | AdoptedNov 18, 2025 | Nov 18, 2026 | 41.0K | 10-K |
| Timothy J. RichmondExecutive Vice President,Chief Human ResourcesOfficer | AdoptedNov 27, 2024 | Jul 1, 2025 | 83.9K | 10-K |
| Perry C. SiatisExecutive Vice President,General Counsel and Secretary | AdoptedNov 19, 2024 | Nov 19, 2025 | 48.6K | 10-K |
As the company states them in Item 9B of the 10-K and Part II, Item 5 of the 10-Q, with structured data. A plan allows sales on preset dates and prices. It does not say whether all of them will be executed.
Executive pay
From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.
$33M
Actually paid: $57M
$12M
Actually paid: $24M
$259
Peers: $187
Adjusted diluted EPS
From the proxy statement (DEF 14A) of Mar 23, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A
Share repurchases
How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.
- Mar 31, 202610-QAmount$1.1B
- Dec 31, 202410-KAmount$353M
- Mar 31, 202410-QAmount$960M
- Mar 31, 202310-QAmount$1.6B
- Dec 31, 202210-KAmount$4.5M
- Mar 31, 202210-QAmount$1.1B
- Dec 31, 202110-KAmount$124M
- Mar 31, 202110-QAmount$555M
| Quarter | Shares | Average price | Amount | Left in the program | Filing |
|---|---|---|---|---|---|
| Mar 31, 202610-Q | 4.62M | $230.40 | $1.1B | $1.8B | 10-Q |
| Dec 31, 202410-K | 2.03M | $173.84 | $353M | $3.5B | 10-K |
| Mar 31, 202410-Q | 5.32M | $180.44 | $960M | $3.8B | 10-Q |
| Mar 31, 202310-Q | 10.34M | $153.25 | $1.6B | $4.8B | 10-Q |
| Dec 31, 202210-K | 27.9K | $160.67 | $4.5M | $1.4B | 10-K |
| Mar 31, 202210-Q | 7.70M | $146.69 | $1.1B | $1.4B | 10-Q |
| Dec 31, 202110-K | 908.8K | $136.10 | $124M | $2.5B | 10-K |
| Mar 31, 202110-Q | 5.18M | $107.12 | $555M | $2.6B | 10-Q |
From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price. 14 filing(s) not shown, as the table was not read or did not agree with the cash.
The shareholders' vote on pay
The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.
- 2026May 12, 2026For94.7%
- 2025May 13, 2025For93.9%
- 2024May 8, 2024For92.4%
- 2023May 10, 2023For91.2%
- 2022May 11, 2022For89.5%
- 2021May 10, 2021For89.9%
| Year | For | Votes for | Votes against | Abstentions | Broker non-votes | Filing |
|---|---|---|---|---|---|---|
| 2026May 12, 2026 | 94.7% | 1.23B | 69.34M | 11.13M | 239M | 8-K |
| 2025May 13, 2025 | 93.9% | 1.20B | 78.39M | 10.48M | 242M | 8-K |
| 2024May 8, 2024 | 92.4% | 1.17B | 96.64M | 8.48M | 246M | 8-K |
| 2023May 10, 2023 | 91.2% | 1.14B | 109M | 9.92M | 251M | 8-K |
| 2022May 11, 2022 | 89.5% | 1.10B | 129M | 6.63M | 260M | 8-K |
| 2021May 10, 2021 | 89.9% | 1.09B | 123M | 6.17M | 267M | 8-K |
From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XLVState Street(R) Health Care Select Sector SPDR(R) ETFWeight in the fund7.74%
- IYHiShares U.S. Healthcare ETFWeight in the fund7.32%
- VHTVanguard Health Care Index FundWeight in the fund6.28%
- HDViShares Core High Dividend ETFWeight in the fund6.16%
- IXJiShares Global Healthcare ETFWeight in the fund5.12%
- PPHVanEck Pharmaceutical ETFWeight in the fund4.57%
- DGROiShares Core Dividend Growth ETFWeight in the fund2.96%
- MGVVanguard Morningstar Mega Cap Value Index FundWeight in the fund2.09%
- DGRWWisdomTree U.S. Quality Dividend Growth FundWeight in the fund2.07%
- PVALPutnam Focused Large Cap Value ETFWeight in the fund1.94%
76 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 3,919
- Q4 2025: Managers 4,169
- Q1 2026: Managers 4,112
- Q2 2026: Managers 4,216
Institutional investors by quarter
The fund managers holding ABBV, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 4,216 managers held 1.34B shares, worth $336B. During the quarter 284 opened a position, 180 closed one, 1,852 added and 1,501 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter-0.8%
- Vanguard Capital ManagementIn the quarter+0.4%
- State StreetIn the quarter+1.7%
- Vanguard Portfolio ManagementIn the quarter-2.1%
- JPMorgan ChaseIn the quarter-16%
- Geode Capital ManagementIn the quarter+0.6%
- Morgan StanleyIn the quarter+2.3%
- Capital Research Global InvestorsIn the quarter-3.7%
- Norges BankIn the quarter-0.4%
- Bank of AmericaIn the quarter-11%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 149M | -0.8% | $37.6B |
| Vanguard Capital Management | 115M | +0.4% | $29.0B |
| State Street | 82.60M | +1.7% | $20.8B |
| Vanguard Portfolio Management | 48.48M | -2.1% | $12.2B |
| JPMorgan Chase | 47.86M | -16% | $12.2B |
| Geode Capital Management | 47.00M | +0.6% | $11.8B |
| Morgan Stanley | 38.90M | +2.3% | $9.8B |
| Capital Research Global Investors | 30.10M | -3.7% | $7.6B |
| Norges Bank | 25.55M | -0.4% | $6.4B |
| Bank of America | 21.24M | -11% | $5.3B |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
The full analysis
What do AbbVie's filings show?
Who buys and sells is one part of AbbVie's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have ABBV's insiders bought or sold?
From Jul 2, 2026 to Nov 12, 2026 AbbVie's insiders bought 0 and sold $20M of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold ABBV?
7 of the managers we track held the shares on Jun 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $798M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.